q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

September 2020 Medicare Drug List Updates: Fourty-six (46) medications added to 2020 Medicare Part D Drug plan formularies.

Category: Monthly Formulary Changes
Published: Sep, 29 2020 05:09:18
< Previous
Next >
We now have the recently released September 2020 Medicare Part D prescription drug plan formulary (drug lists) data online and included in our Formulary Browser and Q1Rx Drug Finder.

The September formulary updates include the addition of 86 new National Drug Codes (NDCs), representing 46 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the September 2020 Formulary update include 13 newly-added generic drugs

The September Medicare Part D drug data includes 18 new generic medications, 13 of which are newly-introduced generic drugs.  These new generic drugs include:
  • CEFDINIR [Omnicef®],
  • DEXABLISS [ZCORT®],
  • DICLOFENAC EPOLAMINE [Licart®],
  • METHYLPHENIDATE ER [Aptensio XR®],
  • METHYLPHENIDATE ER [Metadate CD®],
  • MICAFUNGIN [Mycamine®],
  • NALOXONE [EVZIO®],
  • NITISINONE [Orfadin®],
  • NIZATIDINE [Axid®],
  • POTASSIUM CL,
  • TERIPARATIDE [Forteo®],
  • VTOL LQ, and
  • ZIPRASIDONE [Geodon®].

You can see our article "September 2020 Drug List Updates: Eighteen (18) new generic drugs added to many Medicare Part D plan formularies." found at https://Q1News.com/867.html for more about coverage the new generics.


The September 2020 Formulary update includes sixteen (16) newly-added brand-name drugs

The September drug data updates also include twenty-eight (28) new brand-name drugs, sixteen (16) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • ARAZLO®,
  • Bynfezia®,
  • DAYVIGO®,
  • HELIDAC THERAPY®,
  • ISTURISA®,
  • LYUMJEV®,
  • NEXLIZET®,
  • ORIAHNN®,
  • QINLOCK®,
  • RELAFEN DS®,
  • RETEVMO®,
  • TABRECTA®,
  • TUKYSA®,
  • XCOPRI®,
  • ZEMDRI®, and
  • ZERVIATE®.
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.


Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155


Summary of September 2020 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 86 new September 2020 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 7
New Delivery Form and Strength 4
New Drug 18
New Drug and Strength 37
New Drug, Delivery Form and Strength 1
New Manufacturer 9
New Manufacturer and Strength 6
New Strength 4
Grand Total 86

The following chart details the 86 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
00187209845ARAZLO 0.045% LOTION06New Drug
62756045236BYNFEZIA 2,500 MCG/ML PEN INJECTOR367New Drug
00781607861CEFDINIR 250 MG/5 ML ORAL SUSPENSION [Omnicef]69391New Drug
00007338313COREG CR 10 MG CAPSULE CPMP 24HR67New Strength
62856041030DAYVIGO 10 MG TABLET09New Drug and Strength
62856040530DAYVIGO 5 MG TABLET09New Drug and Strength
00093351656DEFERASIROX 180 MG TABLET [Jadenu]51333New Manufacturer and Strength
71905040011DEXABLISS 11 DAY 1.5 MG TABLET DS PK [ZCORT]19New Drug
59762070702DICLOFENAC EPOLAMINE 1.3% PATCH TD12 [Licart]2114New Manufacturer and Strength
70569015230DVORAH 325-30-16 MG TABLET [Panlor]07New Drug
58406001004ENBREL 25 MG/0.5 ML SYRINGE64390New Delivery Form
58406004404ENBREL 50 MG/ML MINI CARTRIDGE60382New Delivery Form
58406002104ENBREL 50 MG/ML SYRINGE62390New Delivery Form
60793013230FLECTOR 1.3% PATCH TD12267New Drug
72065012012GVOKE HYPOPEN 2PK 0.5MG/0.1 ML AUTO INJECTOR43272New Delivery Form
72065012112GVOKE HYPOPEN 2-PK 1 MG/0.2 ML AUTO INJECTOR43275New Delivery Form
61958180501HARVONI 33.75-150 MG PELLET PACKET62228New Delivery Form and Strength
61958180401HARVONI 45-200 MG PELLET PACKET62227New Delivery Form and Strength
70199002114HELIDAC THERAPY PACK COMBO PKG010New Drug
55292032060ISTURISA 1 MG TABLET882New Drug and Strength
55292032260ISTURISA 10 MG TABLET882New Drug and Strength
55292032160ISTURISA 5 MG TABLET882New Drug and Strength
59148007928JYNARQUE 15 MG-15 MG TABLET SEQ9170New Strength
59148008028JYNARQUE 30 MG-15 MG TABLET SEQ9170New Strength
00024592001KEVZARA 150 MG/1.14 ML PEN INJECTOR9142New Delivery Form
00024592201KEVZARA 200 MG/1.14 ML PEN INJECTOR9142New Delivery Form
00002820705LYUMJEV 100 UNIT/ML KWIKPEN INSULN PEN129New Drug and Strength
00002772801LYUMJEV 100 UNIT/ML VIAL129New Drug, Delivery Form and Strength
00002822827LYUMJEV 200 UNIT/ML KWIKPEN INSULN PEN129New Drug and Strength
53097057060MARINOL 10 MG CAPSULE04New Drug and Strength
53097056860MARINOL 2.5 MG CAPSULE04New Drug and Strength
53097056960MARINOL 5 MG CAPSULE04New Drug and Strength
42858007645METHYLPHENIDATE ER 15 MG CAPSULE CSBP 40-60 [Aptensio XR]135New Manufacturer
42858008045METHYLPHENIDATE ER 50 MG CAPSULE CSBP 40-60 [Metadate CD]135New Manufacturer
42858007545METHYLPHENIDATE ER 10 MG CAPSULE CSBP 40-60 [Ritalin LA]135New Manufacturer
42858007745METHYLPHENIDATE ER 20 MG CAPSULE CSBP 40-60 [Ritalin LA]134New Manufacturer
42858007845METHYLPHENIDATE ER 30 MG CAPSULE CSBP 40-60 [Ritalin LA]134New Manufacturer
42858007945METHYLPHENIDATE ER 40 MG CAPSULE CSBP 40-60 [Ritalin LA]134New Manufacturer
42858008145METHYLPHENIDATE ER 60 MG CAPSULE CSBP 40-60 [Ritalin LA]135New Manufacturer
51862061001METHYLPHENIDATE LA 20 MG CAPSULE CPBP 50-50 [Ritalin LA]9187New Manufacturer
51862061101METHYLPHENIDATE LA 30 MG CAPSULE CPBP 50-50 [Ritalin LA]9186New Manufacturer
63323072910MICAFUNGIN 100 MG VIAL [Mycamine]46303New Drug and Strength
63323072810MICAFUNGIN 50 MG VIAL [Mycamine]46301New Drug and Strength
72853005102NALOXONE 2 MG AUTO-INJECTOR[EVZIO]218New Drug
72426081803NEXLIZET 180-10 MG TABLET137New Drug
00254302202NITISINONE 10 MG CAPSULE [Orfadin]68368New Drug and Strength
00254302002NITISINONE 2 MG CAPSULE [Orfadin]68368New Drug and Strength
00254302102NITISINONE 5 MG CAPSULE [Orfadin]68368New Drug and Strength
00591313760NIZATIDINE 150 MG CAPSULE [Axid]47334New Drug and Strength
00591313830NIZATIDINE 300 MG CAPSULE [Axid]47335New Drug and Strength
24338026012NYMALIZE 60 MG/10 ML ORAL SYRINGE24123New Drug
00074101756ORIAHNN 300-1-0.5MG/300MG CAPSULE SEQ325New Drug
68025007462OSMOLEX ER 322 MG DAILY DOSE TABLET BP 24H047New Strength
00990925739POTASSIUM CL 20 MEQ-0.45% NACL IV SOLN63359New Manufacturer and Strength
00338070348POTASSIUM CL 40 MEQ/100 ML SOL PIGGYBACK42286New Manufacturer and Strength
73207010130QINLOCK 50 MG TABLET69383New Drug
50228042460RANOLAZINE ER 1,000 MG TABLET 12H [Ranexa]69390New Manufacturer and Strength
50228042360RANOLAZINE ER 500 MG TABLET 12H [Ranexa]69390New Manufacturer and Strength
15370017060RELAFEN DS 1,000 MG TABLET04New Drug
00002397760RETEVMO 40 MG CAPSULE69392New Drug and Strength
00002298026RETEVMO 80 MG CAPSULE69392New Drug and Strength
61958150401SOVALDI 150 MG PELLET PACKET19100New Delivery Form and Strength
61958150501SOVALDI 200 MG PELLET PACKET1999New Delivery Form and Strength
00078070956TABRECTA 150 MG TABLET69393New Drug and Strength
00078071656TABRECTA 200 MG TABLET69393New Drug and Strength
47781065289TERIPARATIDE 620 MCG/2.48 ML PEN INJECTOR [Forteo]13165New Drug
51144000212TUKYSA 150 MG TABLET69393New Drug and Strength
51144000160TUKYSA 50 MG TABLET69393New Drug and Strength
16714065901VENLAFAXINE HCL 100 MG TABLET [Effexor]69393New Drug and Strength
57237017201VENLAFAXINE HCL 25 MG TABLET [Effexor]69393New Drug and Strength
57237017301VENLAFAXINE HCL 37.5 MG TABLET [Effexor]69393New Drug and Strength
57237017401VENLAFAXINE HCL 50 MG TABLET [Effexor]69393New Drug and Strength
57237017501VENLAFAXINE HCL 75 MG TABLET [Effexor]69393New Drug and Strength
70154011116VTOL LQ 50-325-40 MG/15 ML SOLUTION116New Drug
71699010030XCOPRI 100 MG TABLET69393New Drug and Strength
71699020128XCOPRI 12.5-25 MG TITRATION PK TABLET DS PK69391New Drug and Strength
71699015030XCOPRI 150 MG TABLET69393New Drug and Strength
71699020328XCOPRI 150-200 MG TITRATION PK TABLET DS PK69393New Drug and Strength
71699020030XCOPRI 200 MG TABLET69393New Drug and Strength
71699010256XCOPRI 250 MG DAILY DOSE PACK TABLET69392New Drug and Strength
71699010356XCOPRI 350 MG DAILY DOSE PACK TABLET69392New Drug and Strength
71699005030XCOPRI 50 MG TABLET69393New Drug and Strength
71699020228XCOPRI 50-100 MG TITRATION PAK TABLET DS PK69393New Drug and Strength
69097082096ZEMDRI 500 MG/10 ML VIAL653New Drug
71776002430ZERVIATE 0.24% EYE DROP DROPERETTE1771New Drug
43598084858ZIPRASIDONE 20 MG/ML VIAL [Geodon]69387New Drug




Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.



Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.